Concepedia

Paul L. Prather

PL

65

Publications

3.8K

Citations

36

H-Index

1991

Active since

Affiliations

University of Arkansas for Medical Sciences(Current)

Arkansas Department of Health

University of Minnesota

Cayman Chemical (United States)

Texas College

Paul L. Prather is an author at University of Arkansas for Medical Sciences specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

1991–2022

65

Publications

65

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity

Lisa K. Brents, Emily E. Reichard, Sarah M. Zimmerman et al. · PLoS ONE · 2011 · 210 citations · Full text

The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

Jennifer L. Shoemaker, Kathryn A. Seely, Ronald L. Reed et al. · Journal of Neurochemistry · 2007 · 207 citations · Full text

Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton et al. · Drug Metabolism and Disposition · 2012 · 183 citations · Full text

Activation of Cannabinoid CB2 Receptor–Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury

In Young Choi, Chung Ju, Angela M. A. Anthony Jalin et al. · American Journal Of Pathology · 2013 · 152 citations · Full text

, , +15

Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids

Anna Mazur, Cheryl F. Lichti, Paul L. Prather et al. · Drug Metabolism and Disposition · 2009 · 149 citations · Full text

Rows per page

1–5 of 65